Compared with the control group, the ZO-1 and occludin protein expression levels were significantly decreased in the hyperglycemia group, and were significantly increased in the TET2 shRNA transfection group, as compared with the control shRNA transfection group (Fig. 3i, j). The gene discussed is OCLN; the disease is Hyperglycemia.